07/05/2025 11:37
|
Biotechnology
Sydney, Australia – 7 May 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) (“OncoSil” or “the Company”) is pleased to announce the results of the first comparative...